{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:47:57Z","timestamp":1790696877565,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.parkreldis.2013.10.017","type":"journal-article","created":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T04:50:49Z","timestamp":1382590249000},"page":"170-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Dopa-decarboxylase gene polymorphisms affect the motor response to l-dopa in Parkinson's disease"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2417-799X","authenticated-orcid":false,"given":"David","family":"Devos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Lejeune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Cormier-Dequaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Tahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Charbonnier-Beaupel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Rouaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Duhamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Sablonni\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Zahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Costentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Vidailhet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Corvol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2013.10.017_bib1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.parkreldis.2013.10.017_bib3","doi-asserted-by":"crossref","first-page":"S580","DOI":"10.1002\/mds.22037","article-title":"Pharmacokinetics and pharmacodynamics of levodopa","volume":"23","author":"Nutt","year":"2008","journal-title":"Mov Disord"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.parkreldis.2013.10.017_bib4","first-page":"S1","article-title":"The scientific and clinical basis for the treatment of Parkinson disease","volume":"72","author":"Olanow","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib5","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1742-1241.2011.02793.x","article-title":"Pharmacological treatment and the prospect of pharmacogenetics in Parkinson's disease","volume":"65","author":"Kalinderi","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib6","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/mds.22759","article-title":"Levodopa response in early Parkinson's disease","volume":"24","author":"Hauser","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib7","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/BF02532418","article-title":"Aromatic l-amino acid decarboxylase: a neglected and misunderstood enzyme","volume":"21","author":"Berry","year":"1996","journal-title":"Neurochem Res"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib8","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/hmg\/ddi177","article-title":"Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence","volume":"14","author":"Ma","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2217\/14622416.7.8.1159","article-title":"DOPA decarboxylase gene is associated with nicotine dependence","volume":"7","author":"Zhang","year":"2006","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/sj.mp.4000559","article-title":"Two novel variants in the DOPA decarboxylase gene: association with bipolar affective disorder","volume":"4","author":"B\u00f8rglum","year":"1999","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ajmg.b.10030","article-title":"Possible parent-of-origin effect of Dopa decarboxylase in susceptibility to bipolar affective disorder","volume":"117B","author":"B\u00f8rglum","year":"2003","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib12","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/nar\/26.11.2672","article-title":"GAGA factor binding to DNA via a single trinucleotide sequence element","volume":"26","author":"Wilkins","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ana.22155","article-title":"The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial","volume":"69","author":"Corvol","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib14","first-page":"74","article-title":"Effect of controlled- release carbidopa\/levodopa on motor performance in advanced Parkinson's disease","volume":"39","author":"Rondot","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib15","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/mds.24998","article-title":"Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease","volume":"27","author":"Brod","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib16","doi-asserted-by":"crossref","first-page":"11546","DOI":"10.1021\/bi00161a036","article-title":"Tissue specific alternative splicing of the first exon generates two types of mRNAs in human aromatic l-amino acid decarboxylase","volume":"31","author":"Ichinose","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib17","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/mds.20410","article-title":"Genetic polymorphism of catechol-O-methyltransferase and Levodopa pharmacodynamic pattern in patients with Parkinson's disease","volume":"20","author":"Contin","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0304-3940(00)01749-3","article-title":"Genotypes of catechol-O-methyltransferase and response to l-Dopa treatment in patients with Parkinson's disease","volume":"298","author":"Lee","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000074637","article-title":"Association between catechol-O-methyltransferase gene polymorphisms and wearing-off and dyskinesia in Parkinson's disease","volume":"48","author":"Watanabe","year":"2003","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0404.2004.00315.x","article-title":"The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease","volume":"110","author":"Bia\u0142ecka","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00002826-199619040-00001","article-title":"A\u00a0double-blind pharmacokinetic and clinical dose-response study of entacapone as an adjuvant to levodopa therapy in advanced Parkinson's disease","volume":"19","author":"Ruottinen","year":"1996","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/WNF.0b013e31828f3385","article-title":"Pharmacokinetic considerations for the use of levodopa in the treatment of Parkinson disease: focus on levodopa\/carbidopa\/entacapone for treatment of levodopa-associated motor complications","volume":"36","author":"M\u00fcller","year":"2013","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.parkreldis.2013.10.017_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"Power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol Bull"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802013003805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802013003805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:13:54Z","timestamp":1761178434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802013003805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1353802013003805"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2013.10.017","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopa-decarboxylase gene polymorphisms affect the motor response to l-dopa in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2013.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}